離開
進入《TAIPEI TIMES》 Eased rules for vaccinated mulled
A health worker holds a syringe and a vial of the Sinovac COVID-19 vaccine at a market in Bangkok on Wednesday last week. Photo: Reuters
SHORTER QUARANTINE? Health officials said there are scientific and technical challenges to overcome before people who have had a shot could avoid quarantine
By Lee I-chia / Staff reporter
The Central Epidemic Command Center （CECC） is discussing the possibility of allowing people abroad who have been vaccinated against COVID-19 — including with Chinese vaccines — to spend less time in quarantine after arriving in Taiwan, said Minister of Health and Welfare Chen Shih-chung （陳時中）, who heads the center.
In an interview published yesterday in the Chinese-language United Daily News, Chen said that the center is considering reopening the nation’s borders in two stages based on vaccination coverage rates in Taiwan.
The plan for the first stage, when the coverage rate is relatively low, is that inbound travelers can apply for a seven-day quarantine if they have been inoculated overseas, including with Chinese vaccines, but approval would be based on the result of a mandatory COVID-19 test, the minister said.
In the second stage, when the vaccination rate is more than 60 percent, inbound travelers might be exempted from compulsory quarantine, but the decision would be made according to the situation then, he said.
When asked for confirmation of the comments, Centers for Disease Control Deputy Director-General Philip Lo （羅一鈞）, deputy chief of the CECC’s medical response division, yesterday said that the policy is being discussed, but there are scientific and technical challenges.
Asked whether China’s Sinovac vaccine, which was reported to have only about a 50 percent efficacy rate, would also be recognized, Lo said that the policy is to recognize “the fact that the individual has been vaccinated against COVID-19 in another country,” so it would not target any particular vaccine.
The law bans the government from purchasing vaccines manufactured in China, but the planned policy would not exclude travelers who received them, either in China or elsewhere, Lo said.
However, while Chinese vaccine manufacturers have released their own reports, so far final results of phase 3 clinical trials have not been published in accredited international medical journals, and none of them have been authorized by the WHO, the European Medicines Agency or the US Food and Drug Administration, he said.
Therefore, the plan is for inbound travelers who submit proof of having been vaccinated overseas to get paid-out-of-pocket tests after seven days of quarantine in Taiwan and be released from quarantine if the results are acceptable, he said.
The tests would include a polymerase chain reaction and antibody tests, Lo said, but added that there are scientific and technical challenges over how to set standards for antibody tests to ensure that the result indicates that an individual has enough protection against COVID-19.
CECC specialists are still collecting data for further discussion, he added.
Separately, Huang Li-min （黃立民）, head of National Taiwan University Hospital’s pediatrics department and a specialist in infectious diseases, said that several countries that have administered the Sinovac vaccine are still finding it difficult to control their COVID-19 situation, so recognizing Chinese vaccines might be risky.
Asked about the proposed policy, a 28-year-old woman surnamed Chen （陳） said that she does not believe in the efficacy of Chinese vaccines, so people who have been given them might risk infecting people in Taiwan.
The center should not risk the health of people in Taiwan to show friendliness toward China, she said.
Additional reporting by Yang Yuan-ting
新聞來源：TAIPEI TIMES
